| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Philip Alan Director · 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50 | 취득(A) | 192,771 | — | — | 2,000,000 | 간접(I) See Footnote | 아니요 | F1, F2 - F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Philip Alan Director · 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50 | 취득(A) | 2,140,000 | — | — | 2,140,000 | 간접(I) See Footnote | 아니요 | F4, F2 - F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Philip Alan Director · 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50 | 취득(A) | 1,177,000 | — | — | 1,177,000 | 간접(I) See Footnote | 아니요 | F5, F4, F2 - F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
- F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Philip Alan Director · 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 간접(I) See Footnote | 아니요 | F6, F2 - F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Philip Alan Director · 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 간접(I) See Footnote | 아니요 | F7, F6, F2 - F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50 | 취득(A) | 192,771 | — | — | 2,000,000 | 간접(I) See Footnote | 아니요 | F1, F2 - F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50 | 취득(A) | 2,140,000 | — | — | 2,140,000 | 간접(I) See Footnote | 아니요 | F4, F2 - F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50 | 취득(A) | 1,177,000 | — | — | 1,177,000 | 간접(I) See Footnote | 아니요 | F5, F4, F2 - F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
- F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 간접(I) See Footnote | 아니요 | F6, F2 - F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 간접(I) See Footnote | 아니요 | F7, F6, F2 - F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50 | 취득(A) | 192,771 | — | — | 2,000,000 | 직접(D) | 아니요 | F1 - F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
| 제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50 | 취득(A) | 2,140,000 | — | — | 2,140,000 | 직접(D) | 아니요 | F3 - F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
| 제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50 | 취득(A) | 1,177,000 | — | — | 1,177,000 | 직접(D) | 아니요 | F4, F3 - F4 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
- F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
| 제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 직접(D) | 아니요 | F5 - F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
| 제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 23일 2026년 9월 25일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00 | 취득(A) | 1,457,765 | — | — | 1,457,765 | 직접(D) | 아니요 | F6, F5 - F6 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
- F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
| 제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66 | 처분(D) | 1,204,819 | — | — | 0 | 간접(I) See Footnote | 아니요 | F1, F3 - F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
- F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-076681 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Barach Daniele Wolf 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00 | 처분(D) | 839,160 | — | — | 0 | 간접(I) See Footnote | 아니요 | F2, F1, F3 - F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
- F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
- F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-076681 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66 | 처분(D) | 1,204,819 | — | — | 0 | 직접(D) | 아니요 | F1 - F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
| 제출 문서 열기 0001104659-26-076683 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Philip Daniele Barach Family Trust 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00 | 처분(D) | 839,160 | — | — | 0 | 직접(D) | 아니요 | F2, F1 - F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
- F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
| 제출 문서 열기 0001104659-26-076683 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Barach Philip Alan 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66 | 처분(D) | 1,204,819 | — | — | 0 | 간접(I) See Footnote | 아니요 | F1, F3 - F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
- F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-076682 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 19일 2026년 6월 23일 제출 | Barach Philip Alan 10% owner | J Other acquisition or disposition (describe transaction) 파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00 | 처분(D) | 839,160 | — | — | 0 | 간접(I) See Footnote | 아니요 | F2, F1, F3 - F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
- F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
- F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
| 제출 문서 열기 0001104659-26-076682 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Hariri Robert J Director · Officer: Chief Executive Officer | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock | 취득(A) | 3,281 | 0 | — | 2,854,735 | 직접(D) | 아니요 | F1 - F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
| 제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Hariri Robert J Director · Officer: Chief Executive Officer | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | 처분(D) | 1,182 | 1.28 | 1,512.96 산출: 주식 수 × 주당 가격. 정확한 값 1512.96. | 2,853,553 | 직접(D) | 아니요 | F2 - F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
| 제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Hariri Robert J Director · Officer: Chief Executive Officer | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (3,281) | 처분(D) | 3,281 | 0 | — | 0 | 직접(D) | 아니요 | F3, F4 - F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
- F4 On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
| 제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Haines John R Officer: Senior Exec Vice President | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock | 취득(A) | 1,641 | 0 | — | 30,762 | 직접(D) | 아니요 | F1 - F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
| 제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Haines John R Officer: Senior Exec Vice President | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | 처분(D) | 583 | 1.28 | 746.24 산출: 주식 수 × 주당 가격. 정확한 값 746.24. | 30,179 | 직접(D) | 아니요 | F2 - F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
| 제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Haines John R Officer: Senior Exec Vice President | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (1,641) | 처분(D) | 1,641 | 0 | — | 0 | 직접(D) | 아니요 | F3, F4 - F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
- F4 On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
| 제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Brigido Stephen Officer: Pres., Functional Regeneration | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock | 취득(A) | 821 | 0 | — | 9,742 | 직접(D) | 아니요 | F1 - F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
| 제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Brigido Stephen Officer: Pres., Functional Regeneration | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | 처분(D) | 268 | 1.28 | 343.04 산출: 주식 수 × 주당 가격. 정확한 값 343.04. | 9,474 | 직접(D) | 아니요 | F2 - F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
| 제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 4월 13일 2026년 4월 15일 제출 | Brigido Stephen Officer: Pres., Functional Regeneration | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (821) | 처분(D) | 821 | 0 | — | 0 | 직접(D) | 아니요 | F3, F4 - F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
- F4 On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
| 제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 15일 제출 | Ling Geoffrey M.D. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 19,231 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 256,026 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
- F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
| 제출 문서 열기 0001493152-26-002424 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 15일 제출 | Parks Diane L. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 30,000 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 520,021 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
- F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
| 제출 문서 열기 0001493152-26-002427 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 15일 제출 | LeVien Vincent Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 28,847 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 153,847 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
- F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
| 제출 문서 열기 0001493152-26-002423 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 15일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 20,385 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 394,150 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
- F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
| 제출 문서 열기 0001493152-26-002425 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 14일 제출 | Parks Diane L. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 30,000 | 0 | — | 520,021 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-26-002297 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 14일 제출 | LeVien Vincent Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 28,847 | 0 | — | 153,847 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-26-002300 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 14일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 20,385 | 0 | — | 394,150 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-26-002298 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 1월 12일 2026년 1월 14일 제출 | Ling Geoffrey M.D. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 19,231 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 256,026 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-26-002303 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Parks Diane L. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 125,000 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 490,021 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029615 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Parks Diane L. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) 파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20 | 취득(A) | 156,250 | 0 | — | 518,774 | 직접(D) | 아니요 | F3 - F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029615 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 125,000 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 373,765 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029614 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) 파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20 | 취득(A) | 156,250 | 0 | — | 518,774 | 직접(D) | 아니요 | F3 - F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029614 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | LeVien Vincent Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 125,000 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 125,000 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029618 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | LeVien Vincent Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) 파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20 | 취득(A) | 156,250 | 0 | — | 156,250 | 직접(D) | 아니요 | F3 - F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029618 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Ling Geoffrey M.D. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 125,000 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 236,795 | 직접(D) | 아니요 | F1, F2 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029617 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 29일 2025년 12월 30일 제출 | Ling Geoffrey M.D. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) 파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20 | 취득(A) | 156,250 | 0 | — | 1,490,996 | 직접(D) | 아니요 | F3 - F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
| 제출 문서 열기 0001493152-25-029617 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 19일 2025년 12월 22일 제출 | Ling Geoffrey M.D. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 67,416 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 111,795 | 직접(D) | 아니요 | F1 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.
| 제출 문서 열기 0001493152-25-028780 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 19일 2025년 12월 22일 제출 | Parks Diane L. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 67,416 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 365,021 | 직접(D) | 아니요 | F1 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested and became exercisable on December 19, 2025.
| 제출 문서 열기 0001493152-25-028787 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 12월 19일 2025년 12월 22일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 67,416 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 248,765 | 직접(D) | 아니요 | F1 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.
| 제출 문서 열기 0001493152-25-028778 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2025년 11월 19일 2025년 11월 21일 제출 | Diamandis Peter Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | 취득(A) | 47,042 | 0.00 | 0 산출: 주식 수 × 주당 가격. 정확한 값 0.00. | 248,765 | 직접(D) | 아니요 | F1 - F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant.
| 제출 문서 열기 0001493152-25-024630 제출 문서의 XML에서 읽음 이 행에 이의 제기 |